All these observations, together with the evidences that relate the lack of p53 with the increase in expression of components of the Wnt/β-catenin pathway, which favour EMT38,78–81, allow us to hypothesize two mechanisms of BCC resistance to MAL-PDT. This evidence concerns the gene TP53 and skin basal cell carcinoma.